Alvaro Ocampo
Dania Beach, FLNPI 1821046079
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,000 of the $4,000 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Spinesmith Holdings, LLC.
Across 1 payment — averaging $4000.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinesmith Holdings, LLC$4K
Across 65 payments — averaging $9646.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$330K
- GSK$224K
- Macrogenics, Inc.$36K
- Idorsia Pharmaceuticals US Inc$32K
- Sumitomo Pharma America, Inc.$5K
What the payments were for
- Consulting fees$4,000100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinesmith Holdings, LLC | 1 | $4,000 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.